ANETUMAB CORIXETAN
UNII NWD16W0E3G

Substance Identification & Data

This profile provides standardized clinical and technical data for Anetumab Corixetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NWD16W0E3G.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
NWD16W0E3G
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ANETUMAB CORIXETAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C174768
National Cancer Institute reference terminology for clinical and research data.
INN ID
11111
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Anetumab Corixetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ANETUMAB CORIXETAN

Common Names & Synonyms

ANETUMAB CORIXETAN [INN]

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus